The group’s principle activity is to develop bacterial therapeutic and genetically modified vaginal Lactobacillus. The group’s products include LACTIN-V vaginal capsule that contains lactic acid and hydrogen peroxide producing bacterium Lactobacillus crispatus. The group operates from United States.
